Your Health Magazine Contributor
4201 Northview Drive
Suite 102
Bowie, MD 20716
More Health Technology Articles
From Code to Medical Device Regulatory Compliance: A Practical Guide for Engineers Working in Medical Devices
Introduction
When engineers set out to develop a medical device, their attention is more toward innovation. The conversations often revolve around improving performance, solving real challenges, software functionality, enhancing algorithms for a better experience for healthcare professionals and patients. Regulatory compliance, meanwhile, is frequently considered as a separate activity that comes into play later in the development process.
However, after working in the medical device industry, in practice, regulatory success is rarely achieved at the end of a project. It is built into the product from day one. Every decision made during development starting from defining the intended use to designing system architecture to implementing software features and managing risks have a direct impact on regulatory requirements and approval pathways.
In today’s healthcare landscape, innovation and compliance move together. The organizations that understand this early are often the ones that bring safer, more effective products to market with fewer delays, fewer redesigns, and a much smoother path to commercialization.
Why Engineers Need to Understand Regulatory Compliance
The medical technology industry is developing rapidly. Traditional hardware devices are increasingly being combined with software, cloud connectivity, artificial intelligence, and data analytics. As products become more innovative, regulatory expectations become more complex as well.
When teams don’t have a clear understanding of regulatory requirements, challenges often show up later in the development process. A straightforward project can suddenly require additional testing, more documentation, or changes to features that affect how the product is classified.
Whereas engineers who understand how their design decisions can influence regulatory requirements, are better positioned to avoid these setbacks. By considering compliance early in development, teams can make timely decisions, plan more effectively, and move through development with greater confidence.
Every Medical Device Starts with Two Questions
Before regulators evaluate technology, they first want to understand its intended use.
Two questions form the foundation of every regulatory strategy:
• What medical purpose is the product intended to serve?
• How does the product achieve that purpose?
The answers determine whether a product is regulated as a medical device, an in vitro diagnostic device, software as a medical device, or potentially a non-medical wellness product. For engineers, this means that even small changes in functionality can have more regulatory consequences. A feature that appears simple may alter the intended use of the product and affect the entire regulatory pathway.
Understanding Risk-Based Regulation
Though regulatory frameworks are different across regions, they follow a common principle, “the higher the risk to patients and users, the greater the level of regulatory oversight”. The U.S. Food and Drug Administration (USFDA), European Union Medical Device Regulation (EU) 2017/745 (EUMDR), and Central Drugs Standard Control Organization (CDSCO) are regulatory bodies that classify devices into Class I to III / Class A to D to determine the applicable regulatory requirements based on risk to patients. Medical device regulations vary significantly between the US and Europe, even though both use risk-based approaches.
Products that present lower risks generally require less documentation, while higher-risk devices demand more documentation and its validation, clinical data, and technical formalities. This concept is particularly important for engineering teams. Features such as automation, connectivity, decision support, and diagnostic functionality can directly influence a product’s classification and the level of evidence required for approval. IMDRF develops international guidelines to support harmonization across jurisdictions and improve access.
The Growing Importance of Software in Medical Devices
Software has become one of the most important elements in modern healthcare technology. In many cases, software itself performs the primary medical function, known as Software as a Medical Device (SaMD), which IMDRF defines as software intended for medical purposes that performs those purposes without being part of hardware. IMDRF also formed a SaMD working group in 2013 to develop guidance in this area.
The regulatory classification of software often depends on the degree to which it influences clinical decisions.
Software that simply provides information may be considered at low risk. Applications that influence treatment decisions have greater regulatory attention. Software that directly diagnoses conditions or guides critical clinical interventions generally falls into higher-risk categories.
As software capabilities expand, engineers must understand that code is no longer just a technical asset; it is often a regulated component of the medical device itself, and clearer international frameworks help enable safer innovation and access to compliant software-based products.
Common Risk Management Pitfalls During Development
Currently in the industry, several repeated challenges continue to appear early in product development, especially during Phase I planning, research, and documentation.
One of the most common is treating regulatory compliance as a document exercise rather than a design consideration. Another is failing to define the intended use clearly at the beginning of the project, when Phase II should focus on developing the concept and proving feasibility before features that affect compliance are locked in. Teams may also fail to recognize how software updates, artificial intelligence functions, or new user features can impact regulatory requirements.
Almost all organizations, the engineering, quality, and regulatory team works in parallel rather than collaboratively. This separation can create gaps in understanding and lead to unnecessary delays later in the development process.
Practical Steps Engineers Can Take
Engineers don’t need to be regulatory experts for this. However, developing a basic understanding of key principles can significantly improve project outcomes.
A practical starting point is to involve regulatory and quality professionals during the earliest stages of product planning, so the company can build its quality management system around ISO 13485:2016. ISO 13485:2016 is the core standard for medical device quality management systems, helping manufacturers maintain documented procedures across development and manufacturing while supporting an effective quality system. Early discussions often identify challenges early before unexpected problems arise.
Engineers should also become familiar with device classification principles and understand how variation in product features affects regulatory requirements. It is important to adopt a risk-based mindset throughout development, including early risk analysis. Every design decision should consider its potential impact on patient safety and product effectiveness and not only its performance.
Viewing Regulations as an Advantage
Regulations are often understood as hurdles that slow innovation, but in practice, they serve a different purpose. Regulatory frameworks provide a structured approach to developing products that are safe, effective, and reliable.
Organizations that include regulatory thinking from the ideation stage typically experience fewer redesign cycles, stronger product quality, and more predictable approval timelines. Regulatory awareness also helps build confidence among healthcare professionals, patients, investors, and regulatory authorities.
Hence, compliance becomes more than a requirement; it becomes a competitive advantage.
Final Thoughts
The relationship between engineering and regulatory affairs is becoming stronger day by day. As medical technologies continue to evolve, engineers play an important role in ensuring that innovation reaches patients safely and effectively.
Understanding regulatory principles helps engineering teams integrate compliance into product development from the outset, supporting safer products and more predictable regulatory pathways.
The future of medical technology belongs to teams that can bring together technical excellence and regulatory compliance. For modern engineers, that bridge starts with understanding that compliance is not the final destination; it is an integral part of the design journey itself. By combining engineering expertise with a strong focus on quality, safety, and regulatory requirements, engineering teams can help bring innovative medical devices to market more efficiently while supporting patient safety and regulatory compliance.
FAQs:
1. What regulations and standards should engineers understand when developing medical devices?
Engineers should understand FDA, EU MDR, CDSCO, ISO 13485, ISO 14971, IEC 62304, and cybersecurity requirements. Depending on the target market, they may also need to follow other regulatory bodies and international frameworks, and EUDAMED is mandatory for UDI and operator registration in the EU as of 28th May, 2026.
2. What are Design Controls, and why are they important for engineers?
Design Controls ensure traceable, safe, and effective development through defined inputs, outputs, verification, validation, and reviews.
3. Why is risk management important throughout the medical device development process?
Risk management identifies, evaluates, and controls hazards throughout development, helping ensure safety, effectiveness, and regulatory compliance.
4. How do software and cybersecurity requirements impact medical device development?
Software and cybersecurity requirements ensure secure, reliable, and compliant products while protecting patient safety and sensitive data.
5. When should regulatory affairs teams become involved in a medical device project?
For medical device companies and medical device manufacturers, regulatory teams should be involved from initiation through launch of a new medical device to guide medical device design decisions, classification, compliance strategy, approvals, and whether significant changes must be reported to authorities, especially in Europe.
Author’s bio
Deep Modi is a Subject Matter Expert in Regulatory Affairs for Medical Devices at eInfochips. With over 13 years of experience in the medical device industry, he has worked across the entire product lifecycle from concept development and design to manufacturing, regulatory submissions, and market commercialization. His expertise spans global regulatory frameworks, including U.S. FDA, EU MDR, MDSAP, and CDSCO requirements, helping manufacturers navigate complex compliance pathways and successfully bring medical devices to market. Throughout his career, Deep has supported numerous medical device programs, guiding them from ideation and development through regulatory approval and commercial launch. Deep holds a master’s degree in biomedical engineering and is currently pursuing a PhD in Biomedical Engineering, with a focus on advancing healthcare technologies. He is also a certified Lead Auditor for ISO 13485 and has extensive experience in applying ISO 14971 risk management principles throughout the medical device development lifecycle.
LinkedIn: www.linkedin.com/in/deep-modi
Other Articles You May Find of Interest...
- Smart Home Health Devices: Are Your Network Details Leaking Confidential Data?
- 12 Healthcare App Development Companies in 2026 – 2027
- 10 Healthcare IT Consulting Companies for Digital Transformation in 2027
- The Laboratory of the Future: Automation, AI and Smarter Scientific Research
- Hyperbaric Oxygen Therapy and Recovery: What Consumers Should Know About HBOT
- The Overlooked Materials Behind Safer Surgery
- AI in Healthcare: Pros and Cons Patients Should Know











